BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11518059)

  • 1. A current review of the antimicrobial activity of Hypericum perforatum L.
    Reichling J; Weseler A; Saller R
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S116-8. PubMed ID: 11518059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further degradation product of hyperforin from Hypericum perforatum (St John's Wort).
    Vajs V; Vugdelija S; Trifunović S; Karadzić I; Juranić N; Macura S; Milosavljević S
    Fitoterapia; 2003 Jul; 74(5):439-44. PubMed ID: 12837358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with Hypericum perforatum L. does not trigger decreased resistance in Staphylococcus aureus against antibiotics and hyperforin.
    Hübner AT
    Phytomedicine; 2003 Mar; 10(2-3):206-8. PubMed ID: 12725578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
    Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria.
    Schempp CM; Pelz K; Wittmer A; Schöpf E; Simon JC
    Lancet; 1999 Jun; 353(9170):2129. PubMed ID: 10382704
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
    Vormfelde SV; Poser W
    Arch Intern Med; 2000 Sep; 160(16):2548-9. PubMed ID: 10979074
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
    Fourneron JD; Naït-Si Y
    Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L; Appendino G; Jakupovic J; Bombardelli E
    J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
    J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study.
    Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC
    J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The production of hypericins and hyperforin by in vitro cultures of St. John's wort (Hypericum perforatum).
    Kirakosyan A; Sirvent TM; Gibson DM; Kaufman PB
    Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):71-81. PubMed ID: 14521510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction.
    Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC
    Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three new hyperforin analogues from Hypericum perforatum.
    Shan MD; Hu LH; Chen ZL
    J Nat Prod; 2001 Jan; 64(1):127-30. PubMed ID: 11170687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
    Murch SJ; Rupasinghe HP; Saxena PK
    Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.